Related Experiment Video
Updated: Sep 25, 2025
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
Significance of metastamiR-10b in breast cancer therapeutics
Apexa Raval1, Jigna Joshi1, Franky Shah2
1Molecular and Diagnostic Research Lab-4, Department of Cancer Biology, The Gujarat Cancer & Research Institute, Ahmedabad, India.
Background:
Breast cancer is a fatal disease and a major reason of cancer associated death in females. Many factors along with miRNA are responsible for the development and the progression of the disease. The miRNA plays a very crucial role in the regulation of the genes. MicroRNAs are of three major types-oncomiRs, tumor suppressive miRNAs, and metastamiRs.
Main Body:
MicoRNA-10b is a prometastatic microRNA targeting various genes that facilitates multiple outcomes such as metastasis, increased capacity for invasion, proliferation and migration, increased epithelial-mesenchymal transformation, angiogenesis, and therefore exhibits worse clinical outcomes. It is found to be upregulated in various malignancies and is thus to be considered as the possible therapeutic candidate.
Conclusion:
The therapeutic delivery of miR-10b antagonists (antagomiRs) and/or knockdown of miRNA is beneficial in reducing tumor growth. Additionally, combination therapy which includes antisense oligonucleotides using miR-10b can function as an effective approach to tumor regression and drug resistance reversal.
Insights
MicroRNA-10b (miR-10b) promotes breast cancer metastasis. Inhibiting miR-10b through antagomiRs or gene knockdown can reduce tumor growth and reverse drug resistance, offering a potential therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Breast cancer is a leading cause of cancer-related death in women.
- MicroRNAs (miRNAs) are key regulators of gene expression involved in cancer development.
- miRNAs are classified as oncomiRs, tumor suppressive miRNAs, and metastamiRs.
Purpose of the Study:
- To investigate the role of microRNA-10b (miR-10b) in breast cancer progression.
- To evaluate the therapeutic potential of targeting miR-10b.
Main Methods:
- Analysis of miR-10b expression in malignancies.
- Investigating the effects of miR-10b antagonists (antagomiRs) and gene knockdown.
- Exploring combination therapy with antisense oligonucleotides targeting miR-10b.
Main Results:
- MicroRNA-10b is a pro-metastatic miRNA.
- miR-10b upregulation is associated with increased invasion, proliferation, migration, epithelial-mesenchymal transition, and angiogenesis.
- miR-10b is upregulated in various malignancies, indicating its potential as a therapeutic target.
Conclusions:
- Therapeutic delivery of miR-10b antagonists or knockdown of miR-10b effectively reduces tumor growth.
- Combination therapy involving antisense oligonucleotides targeting miR-10b shows promise for tumor regression and overcoming drug resistance.
Related Concept Videos
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:38Mitogens and the Cell Cycle